Rationale Documents Rationale documents pertaining to breakpoints determined by the EUCAST Veterinary Subcommittee. Florfenicol (Cattle) Rationale for EUCAST clinical breakpoints, version 1.0 10 August 2019 Download PDF Amoxicillin-Clavulanic Acid (AMC) Dog: oral and iv administration (VetCAST)…
Get to know moreRationale Documents The EUCAST Rationale Documents currently available are listed below. Rationale documents for antifungal agents are listed elsewhere, see " Antifungal rationale documents ". A template for companies aiming to create a comprehensive rationale document for new agents or for existing…
Get to know moreThe two rationale documents on itraconazole (Candida spp and Aspergillus spp) were amalgamated and updated as Itraconazole rationale document v 3.0 (2021),
Get to know moreSitemap EUCAST - Home About EUCAST Organisation Steering Committee General Committee EUCAST Statutes National AST Committees (NAC) Network Laboratories Development Laboratories (EDL) Subcommittees Antimycobacterial Susceptibility Testing (AMST) Antifungal Susceptibility Testing (AFST) Veterinary…
Get to know moreDevelopment of clinical breakpoints and ECOFFs As with other breakpoints for antimicrobials the background for EUCAST breakpoints are given in Rationale Documents. Since for antifungals specific technical issues in testing may exist, technical notes are developed if needed. As with the general…
Get to know moreDevelopment of Clinical Breakpoints and ECOFFs These pages collate information on the definition of clinical breakpoints and the process of setting MIC breakpoints. Background information is given in the Rationale Documents and in Public Consultations and the MIC:ZD (MIC vs. zone diameter)…
Get to know moreRationale documents Amphotericin B v 3.0 (26 June 2025) Anidulafungin vs. Candida v 5.0 (26 June 2025) Caspofungin vs Candida - there is no caspofungin RD and no specific caspofungin breakpoints. Use anidulafungin and micafungin as markers for caspofungin susceptibility where isolates "S" to both…
Get to know moreTen new or updated Rationale Documents published, all identifiable in the list of documents by the date 2021-02-08).
Get to know moreThe following ECOFFs and breakpoints for antifungal agents have been established or revised and are now found in the associated revised rationale documents, the breakpoint document and the ECOFF and breakpoints document available at the EUCAST website: Download PDF
Get to know moreThe delafloxacin rationale document has been updated.
Get to know more
We’ve prepared a short video to help you get familiar with the new layout and features.